Is it time for ACE inhibitors in chronic allograft nephropathy?

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Kidney Diseases

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0272-6386(00)70315-5PMID 10620559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.

  2000cited by this paper
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

  1997cited by this paper
• Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

  1996cited by this paper
• Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

  1996cited by this paper
• Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.

  1994cited by this paper
• Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria

  1994cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1993cited by this paper
• Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic Patients

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Renal protective effect of enalapril in diabetic nephropathy.

  1992cited by this paper
• Renal protective effect of enalapril in diabetic nephropathy: Author's reply

  1992cited by this paper
• Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension.

  1986cited by this paper
• Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.

  1986cited by this paper
• Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

  1986cited by this paper
• Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.

  1985cited by this paper
• Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.

  1983cited by this paper
• Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

  1983cited by this paper
• EDUCATIONAL GRAFFITI: BETTER USE OF THE LAVATORY WALL

  1982cited by this paper
• Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys.

  1978cited by this paper
• Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.

  1976cited by this paper

• Issues and concerns in the management of progressive allograft dysfunction: A narrative review

  2022cites this paper
• Drug Interactions in Solid Organ Transplant Recipients

  2014cites this paper
• Drug interactions in transplant patients: what everyone should know

  2009cites this paper
• Chronic Kidney Disease Management: Comparison between Renal Transplant Recipients and Nontransplant Patients with Chronic Kidney Disease

  2007cites this paper
• Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.

  2006cites this paper
• Hypertension in kidney transplantation.

  2005cites this paper
• ACE inhibition in the treatment of children after renal transplantation

  2004cites this paper
• Does Angiotensin II Modulate Erythropoietin Production in HepG2 Cells?

  2004cites this paper
• The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function.

  2004cites this paper
• THERAPEUTIC EFFECTS OF ANGIOTENSIN II INHIBITION OR BLOCKADE ON THE PROGRESSION OF CHRONIC RENAL DISEASE

  2003cites this paper
• The effect of rapamycin after cyclosporin dose reduction on chronic allograft nephropathy

  2003cites this paper
• Interaction of cyclosporine A and the renin-angiotensin system; new perspectives.

  2002cites this paper
• Angiotensin‐II receptor antagonist losartan reduces microalbuminuria in hypertensive renal transplant recipients

  2002cites this paper
• Susceptibility to T Cell-Mediated Injury in Immune Complex Disease Is Linked to Local Activation of Renin-Angiotensin System: The Role of NF-AT Pathway1

  2002cites this paper
• Mortality after kidney transplant failure: the impact of non-immunologic factors.

  2002cites this paper
• CYCLOSPORINE INDUCES MYOCARDIAL CONNECTIVE TISSUE GROWTH FACTOR IN SPONTANEOUSLY HYPERTENSIVE RATS ON HIGH-SODIUM DIET1

  2001cites this paper
• ACE inhibitors for all—‘Hope’ for the heart and failure for the kidneys?

  2001cites this paper
• Can ACE inhibitors prevent chronic allograft failure?

  2001cites this paper
• Use of angiotensin-converting enzyme inhibitors and angiotensin II antagonists in renal transplantation: Delaying the progression of chronic allograft nephropathy?

  2000cites this paper
• Angiotensin II: an immune costimulator?

  2000cites this paper
• Management strategies for posttransplant hypertension.

  2000cites this paper